Biote - רווח למניה בשנים עשר החודשים האחרונים BTMD

biote Corp. (BTMD) provides health optimization services, the demand for which may fluctuate during declines in consumer income. This price chart illustrates the EPS TTM dynamics, which currently stands at -108.80. The company is developing nano-analysis and cloud-based dosing systems, maintaining its leadership in bioidentical therapy. GMP-certified facilities and the pristine condition of drug production equipment ensure business stability.
Biote - פילוחים אנליטיים ומדדי מפתח (BTMD)

Year-over-year (YoY) EPS growth (TTM) measures the dynamics of net income per share over a rolling year, reflecting the actual efficiency of capital generation. Investors evaluate this rate to identify stagnation or acceleration in the business's fundamental development. By analyzing the 12-month history of EPS YoY changes, one can determine the sustainability of returns for biote Corp. (BTMD). This metric confirms the success of the diversification strategy through hormone therapy, dietary supplements, and educational programs.